IBDEI15U ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20777,1,4,0)
 ;;=4^724.5
 ;;^UTILITY(U,$J,358.3,20777,1,5,0)
 ;;=5^Back Pain, Chronic
 ;;^UTILITY(U,$J,358.3,20777,2)
 ;;=^12250
 ;;^UTILITY(U,$J,358.3,20778,0)
 ;;=600.00^^131^1296^13
 ;;^UTILITY(U,$J,358.3,20778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20778,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,20778,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,20778,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,20779,0)
 ;;=490.^^131^1296^16
 ;;^UTILITY(U,$J,358.3,20779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20779,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,20779,1,5,0)
 ;;=5^Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,20779,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,20780,0)
 ;;=682.8^^131^1296^19
 ;;^UTILITY(U,$J,358.3,20780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20780,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,20780,1,5,0)
 ;;=5^Cellulitis NEC
 ;;^UTILITY(U,$J,358.3,20780,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,20781,0)
 ;;=585.9^^131^1296^20
 ;;^UTILITY(U,$J,358.3,20781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20781,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,20781,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,20781,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,20782,0)
 ;;=428.0^^131^1296^17
 ;;^UTILITY(U,$J,358.3,20782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20782,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,20782,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,20782,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,20783,0)
 ;;=496.^^131^1296^18
 ;;^UTILITY(U,$J,358.3,20783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20783,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,20783,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,20783,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,20784,0)
 ;;=414.01^^131^1296^21
 ;;^UTILITY(U,$J,358.3,20784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20784,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,20784,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,20784,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,20785,0)
 ;;=311.^^131^1296^22
 ;;^UTILITY(U,$J,358.3,20785,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20785,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,20785,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,20785,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,20786,0)
 ;;=250.01^^131^1296^23
 ;;^UTILITY(U,$J,358.3,20786,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20786,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,20786,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,20786,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,20787,0)
 ;;=250.00^^131^1296^24
 ;;^UTILITY(U,$J,358.3,20787,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20787,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,20787,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,20787,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,20788,0)
 ;;=305.90^^131^1296^26
 ;;^UTILITY(U,$J,358.3,20788,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20788,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,20788,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,20788,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,20789,0)
 ;;=305.93^^131^1296^25
 ;;^UTILITY(U,$J,358.3,20789,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20789,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,20789,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,20789,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,20790,0)
 ;;=796.2^^131^1296^28
 ;;^UTILITY(U,$J,358.3,20790,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20790,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,20790,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,20790,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,20791,0)
 ;;=607.84^^131^1296^29
 ;;^UTILITY(U,$J,358.3,20791,1,0)
 ;;=^358.31IA^5^2
